FDA Inspection 1272925 — Somerville Acquisitions, Inc.
The FDA completed an inspection of Somerville Acquisitions, Inc. on Jun 4, 2025 in Flemington, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Flemington, NJ (United States)